ABSTRACT: Ochratoxin A, is a food-borne mycotoxin produced by several fungal species of the genera Aspergillus and Penicillium. Ochratoxin A was dissolved in corn oil and given by gastric intubation to rabbits on days 6-18 of gestation with the dose levels of 0.025, 0.050 and 0.100 mg/kg body weight. When compared with controls (4.16 %), in case of 0.100 mg/kg dose group, there was a significant increase in the incidence of gross (P<0.05) and skeletal (P<0.10) anomalies. The number of live fetuses in the case of 0.100 mg/kg dose group was significantly less than those of the 0.025mg/kg dose group. When compared to controls and 0.025mg/kg dose group, the mean fetal weights and mean fetal crown to rump lengths of dose group 0.100 mg/kg were significantly lower. Major gross anomalies caused by ochratoxin A included wrist drop, rudimentary tail, knuckling of fetlock and agenesis of tail. Skeletal anomalies were agenesis of caudal vertebrae, incomplete ossification of skull bones and wavy ribs. The soft tissue anomalies included internal hydrocephalus, microphthalmia and kidney agenesis.
INTRODUCTION
Ochratoxin A (OA) has gained great importance due to its biological effects and widespread toxicity. OA is nephrotoxic and more importantly, it is implicated as a causal factor of Balkan Endemic Nephropathy (BEN) in humans (STOEV, 1998) . WHO-IARC (1993) designated OA as Group-2B carcinogen (HUSSEIN and BRASEL, 2001) . A widespread awareness of the teratogenic impact of xenobiotics dates back to the discovery of human thalidomide teratogenicity in 1960s (LENZ, 1961) . It is now becoming increasingly evident that a number of food-contaminating metabolites can cause interference with fetal developmental processes. Mycotoxins have emerged as a potential threat to animal and human health in view of their teratogenicity, but a perusal of the reports and the literature scanned shows that the studies in the field of mycotoxin teratogenesis are very limited. Ochratoxin A (OA) has been shown to be teratogenic in rats (STILL et al., 1971; MORE and GALTIER, 1974; BROWN et al., 1976; MAYURA et al., 1982 MAYURA et al., , 1984a MAYURA et al., , 1984b ABDEL-WAHHAB et al., 1999) , mice (HAYES et al., 1974; ARORA; 1982; FUKUI et al., 1987) ; hamsters (HOOD et al., 1976) , chick embryos (GILANI et al., 1975; LALITHA KUNJAMMA and NAIR, 1997) and in quail (DWIVEDI, 1984) . Earlier reports of OA teratogenicity in rats, showed that OA caused a marked increase in the number of foetal deaths and resorptions (STILL et al., 1971; MORE and GALTIER, 1974) . The systematic study of BROWN et al. (1976) using various doses of OA (0.25 to 4 mg/kg body weight) during gestation days 6-15 by oral route induced various gross, visceral and skeletal abnormalities. In a series of studies using the subcutaneous route MAYURA et al. (1982 MAYURA et al. ( , 1984a MAYURA et al. ( , 1984b studied embryocidal, fetotoxic and teratogenic effects of OA, effects of protein deficiency, impaired renal function and protective effects of phenylalanine in OA induced teratogenicity in pregnant rats.
The rabbit is among the most sensitive species to OA toxicity (MARQUARDT and FROHLICH, 1982) , however, no systematic teratogenic studies of mycotoxins, especially OA, appear to have been conducted in rabbits, which are considered as the most suitable laboratory animal models for domestic animals as well as for studying the teratogenic potential of chemicals (WHO, 1967) .
Although exposure to mycotoxin chiefly occurs through the ingestion of contaminated food, the route chosen by earlier workers had often been subcutaneous or intra-peritoneal. As the route of administration can materially influence the teratogenicity of a compound, dosing by oral route appears to be a natural and realistic way for reliable assessment of developmental disorders induced by food borne mycotoxins (ARORA, 1982) . Therefore a detailed, systematic study was planned to elucidate the teratogenic effects of ochratoxin A in rabbits by administering orally in different doses during 6-18 days of gestation.
MATERIALS AND METHODS
Sexually mature (1.5+0. Following an acclimatization period of one week, females were mated with mature males of the same strain. For mating, the female rabbits (in oestrus) were placed in the cages of males at evening and mating was observed. A grunting sound made by the male, who turned to its side after mating was considered as successful mating.
Females were separated the next morning, which was considered as day zero of pregnancy.
Ochratoxin A was produced on sterile maize, using Aspergillus ochraceus NRRL-3174 culture, procured from National Center for Agricultural Utilization Research (NCAUR) Peoria, Illinois, USA as per the method of TRENK et al. (1971) .
For purification of OA, procedures of AOAC (1995) were followed and OA was estimated by using thin layer chromatography along with standard OA procured from Sigma Chemicals Ltd. The quantitative estimation was done by spectrophotometric analysis. The areas covering the spots were marked under the UV light and the silica gel covering each spot was scraped off and collected in separate tubes and extracted with benzene: acetic acid (99:1) and the optical density was recorded at 333nm in UV spectrophotometer and the concentration of OA was calculated. OA was dissolved in corn oil and the rabbits were dosed by gastric intubation at the rate of 0.025, 0.050 and 0.100 mg/kg body weight on days 6-18 of gestation.
Physical condition of each rabbit was assessed daily and on day 30 of gestation the dams were sacrificed and the fetuses were taken out by uterine incision. Each fetus was carefully examined for gross anomalies. Two third of the fetuses were randomly selected and fixed in Bouin's solution and examined for visceral anomalies by Wilson's free hand razor slicing method (WILSON, 1965) . The remaining fetuses were fixed in 70% alcohol, stained with alizarin red S and processed for evaluations of skeletal defects.
Data for maternal observations, such as number of corpora lutea, number of implantations, number of live and dead fetuses, pre-and post-implantation losses and fetal crown to rump lengths and fetal weights were statistically evaluated by analysis of variance (ANOVA) followed by Duncan's test. For the evaluation of gross, skeletal and visceral anomalies a 2 X 2 contingency table test was used (SNEDECOR and COCHRAN, 1967) . In case of ANOVA, a probability of P < 0.05 and in case of 2 x 2 contingency table test P<0.05 and P<0.10 was accepted as significant.
RESULTS

Litter data
The effects of ochratoxin A on total number of corpora lutea, number of implantations, per cent resorptions, number of live and dead fetuses, per cent preand post-implantation losses and fetal crown to rump lengths and fetal weights are summarized in Tables 1 and 2 . There were no maternal mortalities in any group.
There was non-significant decrease in the number of corpora lutea and implantations; however, the number of live fetuses in the 0.100 mg/kg dose group was significantly lower than those of the 0.025 mg/kg dose group. The 0.100 mg/kg dose caused a non-significant increase in the resorptions, pre-and post-implantation losses as compared with those in the control group. There were no dead fetuses in any group.
As compared with the control and 0.025 mg/kg dose group, the mean fetal weights and mean crown to rump lengths were significantly reduced in the case of the 0.100 mg/kg dose group. 
Teratogenic findings
With regard to fetal malformations, OA produced various gross, skeletal and visceral anomalies particularly at the higher dose level (0.100 mg/kg body weight). Table 4 shows various anomalies induced by OA in rabbit fetuses. The incidence of gross anomalies was 3.70%, 8.53% and 31.25% in OA (0.025, 0.050 and 0.100 mg/ kg body weight) treated groups, respectively as compared with that in the control group (4.16%). The gross anomalies observed included wrist drop, rudimentary tail, knuckling of fetlock and agenesis of tail, as compared with that in controls (Fig. 1 ). There was a significant increase (P<0.05) in percent gross anomalies observed at the 0.100 mg/kg dose level than those of controls. Skeletal anomalies were agenesis of caudal vertebrae, incomplete ossification of skull bones and wavy ribs (Fig. 2) .
The skeletal anomalies observed at 0.100 mg/kg dose level showed a significant increase (P<0.10) as compared with that of controls. The soft tissue anomalies included internal hydrocephalus, microphthalmia and kidney agenesis ( Fig. 3 and   4 ). 
DISCUSSION
The literature scanned showed no report on teratogenic effects of ochratoxin A in rabbits, although these are the preferred laboratory animal species and are exclusively recommended for such toxicological studies by regulatory bodies. Such studies may have widespread applications in different species of domestic animals.
Further, OA has been reported to cause outbreaks in rabbits, affecting their production and reproduction (SHALINI, 1996) . Thus, there is a clear need to study the effects of prenatal exposure to ochratoxin A on developing rabbit fetuses. The oral route of administration of OA to pregnant rabbits was selected to simulate the natural mode of ingestion of the toxin under field conditions. BROWN et al. (1976) reported that LD 50 of OA in female rats is 22 mg/kg bw but multiple exposure of doses of OA as small as 0.25 to 0.5 mg/kg bw were teratogenic.
The LD 50 of ochratoxin A in rabbits, determined in this laboratory was 10 mg/kg body weight (MIR et al., 1999) . Moreover, these levels of toxins are also present in the range of natural contamination of the feedstuff ingredients with OA under field conditions (PETZINGER and ZIEGLER, 2000) . Therefore the doses of 0.025, 0.050 and 0.100 mg/kg body weight were selected for present study.
The occurrence of resorptions, pre-and post implantation losses were increased at the highest doses (OA 0.10 mg/kg body weight). There were no dead fetuses in any of the dose groups. The results obtained were in accordance with the earlier reports in rats (BROWN et al., 1976; MAYURA et al., 1982) mice (ARORA, 1982) and hamsters (SCHMIDT and PANCIERA, 1980) . sensitivity of rabbit kidney to OA (MARQUARDT and FROHLICH, 1992) , which is known to be the most potent nephrotoxic agent. Agenesis of kidney has also been reported by MAYURA et al. (1982) in rat fetuses, thus supported the present findings. The absence of kidney observed might be attributed to nephrotoxic effects of OA. The patterns of anomalies observed in rabbit fetuses were similar to those observed in rats (BROWN et al., 1976) , mice (ARORA, 1982) and hamsters (SCHMIDT and PANCIERA, 1980 ). These results indicated that OA is also teratogenic in rabbits, and doses as low as 0.050 mg/kg body weight, when given orally during gestation days 6-18, could cause anomalies in fetuses. The dose of 0.050 mg/kg body weight can also be considered as the minimum oral teratogenic dose for rabbits, however further studies are needed to substantiate this finding.
For the teratogenic mechanism of OA, role of maternal protein deprivation, impaired glycolysis and inactivated phosporylase-b-kinase have been suggested by previous workers (MAYURA, et al., 1983) . OA is known to inhibit mitochondrial respiration and has a direct effect on fetuses, rather than having its action mediated through an effect on the dam (HOOD et al., 1976) .
The localization of 14 C-labelled OA in various organs of fetal mice (APPELGREN and ARORA, 1983) indicated that this mycotoxin caused interference in the development of these organs and continuous exposure due to added doses of the toxin during the organogenesis period were the factors responsible for the appearance of different anomalies of these organs. There is a delicate balance among cell proliferation, cell differentiation and apoptosis in the developing embryo; impairment in these mechanisms caused by OA during the development stages might have been responsible for the anomalies observed.
Although the exact mechanism of OA induced teratogenesis is not clear, the wide spread toxicity of OA as inhibition of DNA, RNA and protein synthesis (MARQUARDT and FROHLICH, 1992) , intracellular transport and subsequent lipid per
